Statement Of Changes In Equity [Abstract]

Xspray Pharma - Filing #679275

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	693 413 SEK	—	554 724 SEK	976,000 SEK	—	—	—	31 253 SEK	184,000 SEK	—	1 216 093 SEK	556 019 SEK	—	—	—	—	976,000 SEK	375 057 SEK	22 680 SEK	- SEK	907 420 SEK	—	—	243 387 SEK	976,000 SEK	813 483 SEK	591 752 SEK	- SEK	20 680 SEK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	179 667 SEK	—	- SEK	—	—	179 667 SEK	—	- SEK	—	—	- SEK	—	—	– SEK	– SEK	131 670 SEK	131 670 SEK	—	—	—	—	—	- SEK	– SEK	—	—	—	—	—	—
Other comprehensive income	184,000 SEK	—	- SEK	—	—	- SEK	184,000 SEK	- SEK	—	—	- SEK	—	—	– SEK	– SEK	– SEK	– SEK	—	—	—	—	—	- SEK	– SEK	—	—	—	—	—	—
Comprehensive income	179 851 SEK	—	- SEK	—	—	179 667 SEK	184,000 SEK	- SEK	—	—	- SEK	—	—	– SEK	– SEK	131 670 SEK	131 670 SEK	—	—	—	—	—	- SEK	– SEK	—	—	—	—	—	—
Issue of equity	342 925 SEK	—	- SEK	—	—	- SEK	—	8 573 SEK	—	—	334 352 SEK	—	—	2 000 SEK	– SEK	100 000 SEK	– SEK	—	—	—	—	—	- SEK	98 000 SEK	—	—	—	—	—	—